SL STRATEGIES, LLC

Lobbying for SEQIRUS · pharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate · $45,000.00 income · posted Jul 22, 2025

Lobbying activity 2

Budget/Appropriations

Fiscal Year 2026 HHS Appropriations bills

Health Issues

Response to the H5N1 influenza outbreak; policies impacting seasonal influenza response

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.